06:31 AM EDT, 07/24/2024 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported fiscal Q2 adjusted earnings Wednesday of $5.37 per share, up from $ 5.15 a year earlier.

Analysts polled by Capital IQ expected $5.13.

Revenue for the quarter ended June 29 was $10.54 billion, down from $10.69 billion a year earlier.

Analysts surveyed by Capital IQ expected $10.52 billion.

The company said it raised its fiscal 2024 adjusted EPS guidance to a range of $21.29 to $22.07, up from its previous guidance of $21.14 to $22.02. Analysts surveyed by Capital IQ expect $21.71.

Revenue for the fiscal year is now projected to be in a range of $42.40 to $43.30 billion, up from its previous guidance of $42.30 to $43.30 billion. Analysts polled by Capital IQ expect $43 billion.

Price: 550.00, Change: -2.24, Percent Change: -0.41